Hoese & Co’s Zimmer Biomet ZBH Stock Holding History

Hoese & Co’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58K	Hold	30	–	–	﹤0.01%	173
2026 Q1	$2.71K	Hold	30	–	–	﹤0.01%	133
2025 Q4	$2.7K	Hold	30	–	–	﹤0.01%	134
2025 Q3	$2.95K	Hold	30	–	–	﹤0.01%	122
2025 Q2	$2.74K	Hold	30	–	–	﹤0.01%	152
2025 Q1	$3.39K	Hold	30	–	–	﹤0.01%	146
2024 Q4	$3.17K	Hold	30	–	–	﹤0.01%	158
2024 Q3	$3.24K	Hold	30	–	–	﹤0.01%	157
2024 Q2	$3.45K	Hold	30	–	–	﹤0.01%	132
2024 Q1	$3.73K	Hold	30	–	–	﹤0.01%	133
2023 Q4	$3.49K	Hold	30	–	–	﹤0.01%	141
2023 Q3	$3.37K	Hold	30	–	–	﹤0.01%	153
2023 Q2	$4.37K	Hold	30	–	–	﹤0.01%	159
2023 Q1	$3.72K	Hold	30	–	–	﹤0.01%	160
2022 Q4	$4K	Hold	30	–	–	﹤0.01%	166
2022 Q3	$3K	Hold	30	–	–	﹤0.01%	182
2022 Q2	$3K	Hold	30	–	–	﹤0.01%	185
2022 Q1	$4K	Sell	30 -1	-3%	-$121	﹤0.01%	185
2021 Q4	$4K	Buy	+31	New	+$4.06K	﹤0.01%	189
2021 Q2	–	Sell	-82	Closed	-$13K	–	215
2021 Q1	$13K	Buy	+82	New	+$12.7K	0.02%	93

Other funds holding ZBH

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

QAM

QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

NCM

Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SFA

Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return

GHAM

Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Hoese & Co's ZBH Position: Q2 2026 in Review

Hoese & Co held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 30 shares worth $2.58K. The position accounts for ﹤0.01% of the portfolio, ranked #173.

Hoese & Co first reported a position in ZBH in Q1 2021 and has held it in 20 quarters since. The position peaked at $13K in Q1 2021. 129 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Hoese & Co held 30 shares of Zimmer Biomet worth $2.58K as of Q2 2026.
Hoese & Co left its Zimmer Biomet share count unchanged in Q2 2026.
Zimmer Biomet made up ﹤0.01% of Hoese & Co's portfolio in Q2 2026, its #173 holding.
Hoese & Co first reported a position in Zimmer Biomet in Q1 2021 and has held it in 20 quarters since.
Hoese & Co's Zimmer Biomet position peaked at $13K in Q1 2021.
129 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Hoese & Co's 13F filing for Q2 2026, filed 14 Jul 2026.